Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Tyrosinase Antibody (T311 + OCA1/812) - IHC-Prediluted, Novus Biologicals™

Mouse Monoclonal Antibody
Supplier: Novus Biologicals NBP248119
Description
Tyrosinase Monoclonal specifically detects Tyrosinase in Human samples. It is validated for Immunohistochemistry, Immunohistochemistry-Paraffin.Specifications
Tyrosinase | |
Monoclonal | |
Unconjugated | |
10mM PBS and 0.05% BSA with 0.05% Sodium Azide | |
TYR | |
Recombinant tyrosinase protein (Uniprot: P14679 ) | |
Protein A or G purified | |
RUO | |
Primary | |
Recognizes a cluster of proteins between 70-80kDa, identified as tyrosinase. Occasionally a minor band at 55kDa is also detected. This monoclonal antibody shows no cross-reaction with MAGE-1 and tyrosinase-related protein 1, TRP-1/gp75. Tyrosinase is a copper-containing metalloglycoprotein that catalyzes several steps in the melanin pigment biosynthetic pathway; the hydroxylation of tyrosine to L-3,4-dihydroxy-phenylalanine (dopa), and the subsequent oxidation of dopa to dopaquinone. Mutations of the tyrosinase gene occur in various forms of albinism. Tyrosinase is one of the targets for cytotoxic T-cell recognition in melanoma patients. Staining of melanomas with this monoclonal antibody shows tyrosinase in melanotic as well as amelanotic variants. This monoclonal antibody is a useful marker for melanocytes and melanomas. | |
Store at 4C. | |
IgG2a κ |
Immunohistochemistry (Paraffin) | |
T311 + OCA1/812 | |
Immunohistochemistry-Paraffin | |
CMM8, EC 1.14.18.1, LB24-AB, Monophenol monooxygenase, OCA1A, OCAIA, SHEP3, SK29-AB, Tumor rejection antigen AB, tyrosinase, tyrosinase (oculocutaneous albinism IA) | |
Mouse | |
75 kDa | |
7 mL | |
Lipid and Metabolism | |
7299 | |
Human | |
Purified |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction